The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma

Abstract

We identified DDIT4 as a cell-intrinsic regulator for adaptive responses and therapy resistance in glioblastoma cells which may interfere with cell death induction by temozolomide, radiotherapy or hypoxia by inhibiting mTORC1 activity.